Skip to main content
Industry Update
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25
- Paul Arora and
- Sreeram V Ramagopalan
e260073
Published Online:16 April 2026
Methodology
Development and validation of a method to compare outcomes between switchers and continuers in routine clinical practice
- Chuan Gao,
- Jenny Jiang,
- Nipun Atreja,
- Amiee Kang,
- Xiaoyan Li, and
- Xuemei Luo
e240099
Published Online:8 May 2026
Efficacy of selpercatinib as a first-line treatment for RET-fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysis
- Jessica E Forsyth,
- Manoj Khanal,
- Urpo Kiiskinen,
- Akkula Jyothi,
- Rajat Goel,
- Tarun Puri,
- Shijie Ren,
- Michael D Sonksen,
- Xiaofei Wang, and
- Min-Hua Jen
e260006
Published Online:29 April 2026
Short Report
Directly comparing randomized and real-world controls in adjuvant breast cancer
- Brigham Walker,
- Marley Boyd,
- Michelle Silver,
- Junxin Shi,
- Purva Bulsara,
- Nino Balanchivadze, and
- Nicholas J Robert
e250143
Published Online:29 May 2026
Research Article
Estimating the societal impact of medical interventions: a case study in metastatic breast cancer
- Foteini Tsotra,
- Kyle Dunton,
- Mats Rosenlund,
- Lena Steinbeck, and
- Sukhvinder Johal
e260005
Published Online:22 May 2026
The value of time savings in breast cancer therapy for patients and healthcare providers: the subcutaneous injection of pertuzumab and trastuzumab fixed-dose combination at a tertiary care center in the UAE
- Khaled H.A. Al Qawasmeh
e260007
Published Online:2 June 2026
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma – Canadian perspective
- Kimberly Guinan,
- Mathieu Pelletier,
- Monika Ham,
- Dipti Tankala,
- Nancy Paul Roc,
- Adi Klil-Drori,
- Anthony W Wang,
- Isabelle Fleury,
- David MacDonald,
- Jean Lachaine, and
- Stephane Barakat
e250187
Published Online:20 April 2026
Transportability of the comparative effect of finerenone for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction of ≥40%: insights from the FINEARTS-HF trial
- Alex J Turner,
- Claire Leboucher,
- Cécile Remuzat,
- Yik Ming Fung,
- Elena Pessina, and
- Kerstin Folkerts
e260003
Published Online:6 May 2026
Matching-adjusted indirect comparison of acoltremon ophthalmic solution 0.003% and cyclosporine 0.05% ophthalmic emulsion for increased tear production in patients with dry eye disease
- Stephen Pflugfelder,
- Tony Okoro,
- Margaret Ainslie-Garcia,
- Anja Haltner,
- Emily K Prentiss,
- Elizabeth M Salvo-Halloran,
- Nikethana Srikanth,
- Michelle Senchyna, and
- Esen K Akpek
e260032
Published Online:14 May 2026
Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost–effectiveness analysis
- Jingran Yang,
- Lei Ren,
- Fengyuan Xie,
- Rong Shao, and
- Rong Jiang
e250189
Published Online:20 May 2026
Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USA
- Glenn Phillips,
- Cynthia Qi,
- Deborah Gelinas,
- Martha Stone,
- Anthony Chamberas,
- Dakshinamoorthy Amirthaganesan,
- Rucha Kulkarni,
- Albert Whangbo, and
- John H Stone
e250141
Published Online:8 May 2026
Meta-Analysis
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis
- Tristan Curteis,
- Lucy A Eddowes,
- Andrei Karlsson,
- Hannah Luedke,
- Manon Rubinstein,
- Mathias Hempfling,
- Jonathan Gurney,
- Bhumi Gandhi-Patel,
- Nathan Unger,
- Uche Mordi,
- Megan Chen,
- James Jarrett,
- Elizabeth M Sherman,
- Karam Mounzer,
- Ann M Khalsa,
- Warren L Dinges,
- Mehri S McKellar, and
- Ashley Lipps
e260013
Published Online:28 May 2026